To address the possibility that the ARID1A/ATRi synthetic lethality might be specific to catalytic inhibition of ATR, we exploited data describing the sensitivity of 86 human tumour cell lines to SMARTPool siRNAs targeting 720 kinase-coding genes34, 35. Here, ARID1A is linked to neoplasm.